Orchid, a reproductive technology company offering the world s only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr.
/PRNewswire/ INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its.